help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cusan, L.
Right arrow Articles by Labrie, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cusan, L.
Right arrow Articles by Labrie, F.

Endocrinology, Vol 104, 1369-1376, Copyright © 1979 by Endocrine Society

ARTICLES

Inhibitory effects of long term treatment with a luteinizing hormone- releasing hormone agonist on the pituitary-gonadal axis in male and female rats

L Cusan, C Auclair, A Belanger, L Ferland, PA Kelly, C Seguin and F Labrie

Following previous observations of the potent antifertility effects of acute treatment with LHRH or its agonistic analogs in male and female rats, this study describes the effect of long term (up to 12 weeks) treatment with an LHRH agonist, [D-Ala6, des-Gly-NH210]LHRH ethylamide (LHRH-A), on testicular and ovarian gonadotropin receptor levels and function in the rat. Treatment of adult male rats with 100 ng LHRH-A every third day led to a progressive decrease of testis, seminal vesicle, and prostate weight up to 12 weeks of treatment, while the inhibitory effect (70%) on LH receptor levels was already maximal at 1 week. When adult female rats were injected daily with 5 microgram LHRH- A for 12 weeks, ovarian LH, FSH, and PRL receptor levels were reduced 50--90%, while plasma estradiol and progesterone levels were inhibited 60% (compared with diestrus day 1). The effect of chronic administration of a low dose (5 IU) of hCG in the male rat was transient. By contrast, no sign of resistance developed up to 12 weeks of treatment with the LHRH agonist in either male or female animals.


This article has been cited by other articles:


Home page
 J EndocrinolHome page
A. Leanos-Miranda, A. Ulloa-Aguirre, L. A Cervini, J. A. Janovick, J. Rivier, and P M. Conn
Identification of new gonadotrophin-releasing hormone partial agonists.
J. Endocrinol., June 1, 2006; 189(3): 509 - 517.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
H. Yang, G. K. Bhat, R. Wadley, K. L. Wright, B. M. Chung, J. A. Whittaker, A. M. Dharmarajan, and R. Sridaran
Gonadotropin-Releasing Hormone-Agonist Inhibits Synthesis of Nitric Oxide and Steroidogenesis by Luteal Cells in the Pregnant Rat
Biol Reprod, June 1, 2003; 68(6): 2222 - 2231.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
W. Paull, C. Turkelson, C. Thomas, and A Arimura
Immunohistochemical demonstration of a testicular substance related to luteinizing hormone-releasing hormone
Science, September 11, 1981; 213(4513): 1263 - 1264.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1979 by The Endocrine Society